GBA PRESENTS- the public games

stonedinvestor said:
Do you mean MARA?


Yeah, I forgot MARA is in to mind altering meds now, crypto mining was a side hustle.

These work well!

upload_2024-7-25_5-10-21.jpeg
 
--Carrier Global plans to repurchase $1B of shares in second half » 06:55 CARR

--
  • Goldman Sachs initiated coverage of LandBridge(LB)with a Buy rating and $35 price target. The firm is constructive on the outlook for the company, saying its New Mexico-Texas Stateline acreage is well positioned to capture continued Permian Basin growth, notably for produced water disposal. Wells Fargo and Raymond James also started coverage of the name with Buy-equivalent ratings. Meanwhile, Barclays, Piper Sandler, and Citi initiated the stock with Neutral-equivalent ratings.
  • Morgan Stanley initiated coverage of Alumis(ALMS)with an Overweight rating and $36 price target. The firm says that while key de-risking catalysts for ESK-001 are in 2026, the stock's current valuation offers an attractive entry point relative to peers. Leerink, Cantor Fitzgerald, and Guggenheimer also started coverage of the name with Buy-equivalent ratings.
 
TD Cowen went turtle on us and lowered Sketcher's PT by a whopping $3

Just keep the fuck quiet! Worthless..... we are going with this sentiment

  • Morgan Stanley upgradedSkechers(SKX)to Overweight from Equal Weight with a price target of $80, up from $60, as part of a broader research note on Branded Apparel and Footwear. The company "scored impressively high" on the firm's global brand momentum and perception survey scorecards, while the recent North America / E.U. sports- wear channel checks for Skechers was also "upbeat," leaving the firm "incrementally positive on the brand."
 
stonedinvestor said:
--Carrier Global plans to repurchase $1B of shares in second half » 06:55 CARR

--
  • Goldman Sachs initiated coverage of LandBridge(LB)with a Buy rating and $35 price target. The firm is constructive on the outlook for the company, saying its New Mexico-Texas Stateline acreage is well positioned to capture continued Permian Basin growth, notably for produced water disposal. Wells Fargo and Raymond James also started coverage of the name with Buy-equivalent ratings. Meanwhile, Barclays, Piper Sandler, and Citi initiated the stock with Neutral-equivalent ratings.
  • Morgan Stanley initiated coverage of Alumis(ALMS)with an Overweight rating and $36 price target. The firm says that while key de-risking catalysts for ESK-001 are in 2026, the stock's current valuation offers an attractive entry point relative to peers. Leerink, Cantor Fitzgerald, and Guggenheimer also started coverage of the name with Buy-equivalent ratings.
More...
CARR is a 2024-2030 play! Lizard God picks solid stocks!
 
Ayyyyyyyyyyyyyyyyyy.

Someday children... Papa will tell you the story about when he owned CRS at $57.... Thought myself smart... I have to check if I was lucky I got $90 but I may of sold in the high $70's.
:banghead:

Super well run company.

CRS Carpenter Technology Corporation

$121.50-3.38(-2.71%)4:00 PM 07/24/24
NYSE |$USD |Pre-Market:$125.00+3.50(+2.88%)8:00 AM
 
stonedinvestor said:
Ayyyyyyyyyyyyyyyyyy.

Someday children... Papa will tell you the story about when he owned CRS at $57.... Thought myself smart... I have to check if I was lucky I got $90 but I may of sold in the high $70's.
:banghead:

Super well run company.

CRS Carpenter Technology Corporation

$121.50-3.38(-2.71%)4:00 PM 07/24/24
NYSE |$USD |Pre-Market:$125.00+3.50(+2.88%)8:00 AM
More...
Why is your VKTX screaming?
 
TrailerParkTed said:
Asking for a friend, how bad was buying MU at $114?
More...



I see why your friend did that. It was an apparently level area but time is always needed./

I just took a peek at the chart.

Worst case $80

most likely case $98.

I would be a buyer at that level---But I give her a shot at stopping right here as well the recent uptrend started at April 19 $106<--- If the market wasn't sour this really would not be a bad spot////
 
TrailerParkTed said:
Why is your VKTX screaming?
More...



It was weird I saw the options were indicating a big move and these bios can't be about $'s at this stage so what are they going to do have earn and say our drug is falling behind?.. Now that i think about this was a no brainer yesterday..

As far as I can tel this all just because they are furthering the process///

VKTX Viking Therapeutics, Inc.

$50.41-1.13(-2.19%)4:00 PM 07/24/24
NASDAQ |$USD |Pre-Market:$58.00+7.59(+15.06%)8:19 AM

Viking sends Lilly, Novo lower as obesity drug enters late-stage program
NewsToday, 7:01 AM
 
You must log in or register to reply here.
Back
Top